Navigation Links
Nicotine, Chili Peppers Offer Post-Surgery Pain Relief
Date:10/15/2007

longer term release patches or lower dose patches, might ease the nausea, Habib said. "The use of nicotine for perioperative analgesia also needs to be studied in smokers, who are unlikely to suffer from the side effect of nausea," he said.

Nicotine patches are approved for use to help smokers quit cigarettes. However, previous studies have shown that nicotine also has some pain-relief benefits. In an earlier study, women who were given a nasal spray containing 3 milligrams of nicotine after a hysterectomy reported less pain or need for morphine, the Duke researcher said.

It's important to note that this study addressed pain related to surgery, not chronic pain, said Edwin W. McClesky, scientific officer at the Howard Hughes Medical Institute, in Chevy Chase, Md., who was not involved with the research. Nicotine patches aren't an answer for chronic pain sufferers, he said.

"Nicotine is a poor solution for anything because it is so addictive," McClesky said. The mechanism by which nicotine may help manage pain after surgery isn't yet known, he added, "because there are nicotine receptors in both the central and peripheral nervous systems."

Habib said short-term analgesic use of nicotine is not addictive. He said future studies will address different doses of nicotine and the drug's effect in different groups of people, such as smokers and women.

In the second study, researchers in Denmark found that purified capsaicin -- a colorless, odorless drug derived from chili peppers -- provided three days of pain relief for men recovering from hernia surgeries.

The researchers placed 1,000 micrograms of purified capsaicin directly into the wounds of approximately 20 men during surgery. The researchers compared the men's postoperative pain with another 20 men who underwent surgery with a placebo instead of capsaicin. Patients in the capsaicin group had significantly lower pain scores during the three days following
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Peppers Kill Prostate Cancer Cells
2. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
5. Roche offers HIV drug expertise to poor nations
6. Magnesium sulfate offers no help in migraine treatment
7. Drug Offers Hope for Alzheimers disease
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Stem cells offer hope for muscular dystrophy
10. Stem Cells Found To Offer Promise For Hair Growth
11. fMRI Offers Insight Into An Infants Brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...t risk may not be accurate in some cases , ...ies, from the United States and the Netherlands, q...shed Framingham Risk Score in predicting heart dis... score, based on findings of a decades-long study ... assess risk on the basis of seven factors: age, g...
(Date:1/8/2009)...re-USNewswire/ -- Today, the National Hospice and ...tional leadership organizations issued a consensus...e and protection of the Medicare Hospice Benefit. ...s unified message about end-of-life care are the A...cine, Hospice and Palliative Nurses Association, N...
(Date:1/8/2009)...anizations offers five action steps to improve res...wire/ -- Despite the recent three-hour cease fires...s to residents of the Palestinian territory, upwar...ean water and medical help. U.S.-based internation...egion see this arrangement to allow sporadic deliv...
(Date:1/8/2009)...urface of cancer cells are keys to the development...ing the spread of certain types of cancers called ...n and lung, among others. Armed with a new two-ye...Research, an Illinois-based philanthropic foundati...nd her co-workers at the Moores Cancer Center at t...
Breaking Medicine News(10 mins):Health News:Studies Challenge Framingham Risk Score 2Health News:Studies Challenge Framingham Risk Score 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 2Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 3Health News:Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot' 2
... as a measure for weight reduction may have the po...of the most common procedures to control morbid ob...e size of the stomach and allows the food to pass ...gether with psychological and behavioral support, ...
...e disease of the substantia nigra ,an area in the ... and its symptoms documented in 1817 by the Britis... biochemical changes in the brain of patients were...re identified only recently, others still remain a...
...who had long earlier published their findings on s...ving ADHD, have come up with the results from the ... association between the two. The follow up data ...ticipants of the original study who had snored reg...
...al Agency for Research on Cancer (IARC) in Lyon, F...kers who are exposed to chronic low doses of radia...cer. This is the largest study ever conducted in 1...rkers. It was estimated that the chronic exposure ...
Other Medicine News:Health News:Re –growing Brain cells destroyed by Parkinson’s disease 2
(Date:1/8/2009)..., Mass. and COLUMBUS, Ohio, Jan. 8 ...prietary nucleic acid assays, today announced that...al Quantitative Assay are complete. , , Under ...linearity, specificity and reproducibility and rob...termined. The data obtain agreed with internally g...
(Date:1/7/2009)...Tenn., Jan. 7 Scientist... a high likelihood of relapse in children with acu...archers caution that further research is needed to... or IKAROS, lead to leukemia relapse, the findin...nostic tests to assess the risk of treatment failu...
(Date:1/7/2009)...Several Products in Development Based On Osteotech...ate Natural BioRegeneration; FDA Filing Anticipate...an. 7 Osteotech, Inc. ...of biologic products for regenerative healing, ann...cal trial for its DuraTech(TM) BioRegeneration Mat...
(Date:1/6/2009)...xpands on Successful Results from prior U.S., U.K....wire/ -- Vital Therapies, Inc. (VTI), a developmen...ounced patient enrollment has begun for a randomiz...al that will study the Extracorporeal Liver Assist...ute Liver Failure (ALF) under three protocols. The...
Breaking Medicine Technology:Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3University of Pennsylvania study reveals inconspicuous hosts in the Lyme disease epidemic 7233 1University of Pennsylvania study reveals inconspicuous hosts in the Lyme disease epidemic 7233 2SEIU Endorses Anderson Perea and Perea in Fresno 7229 1SEIU Endorses Anderson Perea and Perea in Fresno 7229 2FDA Sunscreen Labeling Decision Delayed Another Month Leading U S Physician to Say Enough Is Enough 7225 1FDA Sunscreen Labeling Decision Delayed Another Month Leading U S Physician to Say Enough Is Enough 7225 2Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 1Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 2Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 3
...--(BUSINESS WIRE)--Jun 12, 2007 - Critical,Therape...lication,of data from a pivotal Phase III clinical... tablets in the June 2007 issue of the,Journal of ... Drug,Administration (FDA) on May 30, 2007. Critic...rtner Dey, L.P. (DEY), expects to,begin marketing ...
...ted at EULAR Confirms Efficacy with Either Every,T... June 2007 - 7:00 am CET - New pivotal data,(RAPID...ongress of,Rheumatology (EULAR) show that Cimzia (...anti-TNF, combined with methotrexate,therapy has a...s,and symptoms of active rheumatoid arthritis (RA)...
Other Medicine Technology:Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 2Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 3Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 4Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 5Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 2Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 3Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 4Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 5Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 6Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 7Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 8
The Fluoroskan Ascent, a dedicated microplate fluorometer, offers high sensitivity for a wide variety of fluorometric applications.
DyNA Quant™ 200 is a fixed wavelength fluorometer for 365 nm excitation and 460 nm emission. The spectral characteristics are specifically designed for the detection of double-stranded DNA using
The VICTOR² D fluorometer is suitable for clinical assays based on fluorescence or time-resolved fluorescence from a wide variety of plates.
Liquid, ready-to-use, bar-coded Olympus reagents are convenient, economical easy-to-use and reliable. This is one of 122 tests standardized for use on the Olympus AU400e, AU640e, AU2700, and AU5400 C
Medicine Products: